Navigation Links
Heyltex Corporation to Become Exclusive Distributor of ThyroShield(R)
Date:2/25/2009

Partnership with Fleming Pharmaceuticals to increase access to radiological threat antidote

WASHINGTON, Feb. 25 /PRNewswire-USNewswire/ -- Today, Heyltex Corporation announced an agreement in principle with Fleming Pharmaceuticals for the exclusive distribution of ThyroShield(R) in the United States. ThyroShield(R) Potassium Iodide Oral Solution is a ready-to-use, liquid medicine that protects infants, children, and adults at risk of exposure to radioactive iodine. It is the only FDA-approved liquid potassium iodine product indicated for thyroid protection in a radiation emergency.

By saturating the thyroid gland with potassium iodide, ThyroShield(R) prevents radioactive iodine from being absorbed by the thyroid gland. The product will be available to families through their local pharmacist or online. It is also supplied to the 31 states with commercial nuclear power plants through the Nuclear Regulatory Commission's Program to supply potassium iodide within the 10-mile Emergency Planning Zone and a part of the Department of Health and Human Service's Project BioShield.

"This is an exciting development for Heyltex, as we expand our radiological countermeasure product offerings in the homeland security space," said Alexander Heyl, CEO of Heyltex Corporation. "We're proud that Heyltex is making Americans safer by making ThyroShield(R) available in the event of a radiological attack."

"We are pleased to forge this partnership with Heyltex," said Phill Dritsas, Fleming's President. "This further expands our commitment to ensure that ThyroShield(R) is widely available to meet homeland security needs."

ThyroShield(R) will be the second product addition to the Heyltex portfolio in 2009. Earlier this year, the company began the distribution of Cool Comfort Technology by 32 Degrees(TM) - a new, lightweight, high-absorption cooling fabric that is used in a variety of disaster response and emergency preparedness situations to aid in the temperature moderation of victims and responders.

About Heyltex Corporation

Heyltex Corporation, based in Houston, Texas, was founded in 1979 as a subsidiary of Heyl chemisch-pharmazeutische Fabrik, Berlin Germany. Since 2004, Heyltex has been the exclusive distributor of Radiogardase(R) in the United States. Today, Heyltex is strategically focusing on providing products and solutions to the chemical and pharmaceutical industry. The company is also working to expand the company's product portfolio and market presence by in-licensing, acquiring, and distributing specialty pharmaceuticals, particularly pharmaceutical products related to Homeland Security. Additionally, Heyltex is pursuing opportunities for the distribution of specialty products for the healthcare community. For more information, visit www.heyltex.com.

About Fleming Pharmaceuticals

Fleming Pharmaceuticals, based in Saint Louis County, Missouri, is the manufacturer of the popular OCEAN(R) Premium Saline Nasal Spray, MAGONATE(R) Magnesium Supplement, NEPHROCAPS(R) Softgels, ThyroShield(TM) Potassium Iodide Oral Solution and other specialty prescription and over-the-counter drugs for clinical indications in allergy, pediatrics, nephrology and general nutrition care. For more information, visit www.flemingpharma.com.


'/>"/>
SOURCE Heyltex Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Brooke Franchise Corporation Announces Selected July Results
3. MedThink Communications Retained by NanoBio Corporation
4. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
5. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
6. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
7. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
8. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
9. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
10. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
11. AGA Medical Corporation Receives Approval for the AMPLATZER Muscular Ventricular Septal Defect Occluder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief ... a minimum wage raise to $12 an hour by 2020 and then adjusting it yearly ... lost value of the minimum wage, assure the wage floor does not erode again, and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 VolitionRx ... of Dr. Edward Futcher to the ... effective June 23, 2016.Dr. Futcher was also appointed ... Governance Committees.  As a non-executive member of the ... and strategic counsel to VolitionRx in connection with ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
(Date:6/23/2016)... , June 23, 2016  In a startling report released ... failing their residents by lacking a comprehensive, proven plan to eliminate ... a definitive ranking of how states are tackling the worst drug ... only four states – Kentucky , ... Vermont . Of the 28 failing states, three – ...
Breaking Medicine Technology: